Jung-Chan Ra
Chief Executive Officer en NATURECELL CO.,LTD. .
Fortuna: 12 M $ al 31/03/2024
Perfil
Jung-Chan Ra is currently the Chief Executive Officer & Director at NATURECELL Co., Ltd.
and also holds the position of Chief Executive Officer & Director at Bio Star Korea Co., Ltd.
In the past, he worked as the Chief Executive Officer at R Bio Co., Ltd.
for a brief period in 2011.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
NATURECELL CO., LTD.
2.61% | 30/06/2023 | 1 675 400 ( 2.61% ) | 12 M $ | 31/03/2024 |
Cargos activos de Jung-Chan Ra
Empresas | Cargo | Inicio |
---|---|---|
NATURECELL CO.,LTD. | Chief Executive Officer | 29/01/2016 |
Bio Star Korea Co., Ltd.
Bio Star Korea Co., Ltd. BiotechnologyHealth Technology Part of R Bio Co., Ltd., Bio Star Korea Co., Ltd. is a biotechnology company based in Seoul, South Korea. The South Korean company engages in research and development in biotechnology. The private company was founded in 2009. The CEO is Jung-Chan Ra. | Chief Executive Officer | - |
Antiguos cargos conocidos de Jung-Chan Ra.
Empresas | Cargo | Fin |
---|---|---|
K STECMCELL CO LTD | Chief Executive Officer | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
R Bio Co., Ltd.
R Bio Co., Ltd. Miscellaneous Commercial ServicesCommercial Services R Bio Co., Ltd. operates as a biotechnology company. It engages in the storage and development of stem cells and stem cell drugs. The company was founded on July 05, 1961 and is headquartered in Seoul, South Korea. | Commercial Services |
NATURECELL Co., Ltd. | |
Bio Star Korea Co., Ltd.
Bio Star Korea Co., Ltd. BiotechnologyHealth Technology Part of R Bio Co., Ltd., Bio Star Korea Co., Ltd. is a biotechnology company based in Seoul, South Korea. The South Korean company engages in research and development in biotechnology. The private company was founded in 2009. The CEO is Jung-Chan Ra. | Health Technology |
- Bolsa de valores
- Insiders
- Jung-Chan Ra